Actively Recruiting
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
Led by Melinda Seering · Updated on 2025-11-10
56
Participants Needed
1
Research Sites
123 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter
CONDITIONS
Official Title
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled for reverse shoulder replacement surgery
- ASA class I, II, or III
- Age between 18 and 89 years
- Able to provide informed consent
- Non-emergency surgery
You will not qualify if you...
- Unable to cooperate during block placement
- Do not meet criteria for regional block (e.g., on anticoagulation)
- Significant pulmonary disease or allergy to Exparel, Bupivacaine, or Ropivacaine
- Neuropathy in the arm to be blocked
- Documented kidney failure
- Documented liver failure
- Unable or unwilling to give informed consent
- Currently incarcerated
- Pregnant
- Unable to communicate in English
- Chronic opioid use exceeding 20 MME before surgery
- Fracture
- Revision surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States, 52242
Actively Recruiting
Research Team
M
Melinda Seering, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here